British Journal of Clinical Pharmacology · 1979 · 35 citations · 31 references
MedicineNephrologyPharmacologyExperimental PharmacologyPharmacodynamicsRenal PathophysiologyBlood Pressure ManagementBlood Pressure RegulationHypertension ManagementHypertension PharmacotherapyRenal HemodynamicsRenal PharmacologyAntihypertensive PharmacologyPlasma Renin ActivityRenal HypertensionRenin-angiotensin System BlockadeRenin-angiotensin System InhibitorsRenin-angiotensin-aldosterone System InhibitionRenin-angiotensin-aldosterone System Inhibitors
1 Prolonged infusion (11 h) of both saralasin and angiotensin-converting enzyme inhibitor (SQ20881) gradually lowered BP in two-kidney hypertensive rats to levels similar to that in normotensive rats infused with dextrose. 2 Saralasin did not lower BP in DOCA-salt hypertensive rats. 3 These observations support the notion that in chronic renal hypertension, angiotensin II may maintain hypertension by a slowly developing action. 4 Plasma angiotensin II in rats infused with SQ20881 was suppressed relative to renin, but was not eliminated. 5 Chromatography of angiotensin II extracts from dogs infused with converting enzyme inhibitor (SQ14,225) showed that the very high levels of angiotensin I achieved after treatment with SQ14,225 can lead to falsely high estimated angiotensin II levels as a result of angiotensin I cross-reacting with the angiotensin II assay.
31
Hypertension of Renal Origin: Evidence for Two Different Mechanisms
Hans R. Brunner, J. Dianne Kirshman, Jean E. Sealey et al. · Science · 1971 · 337 citations
Medicine, Nephrology, Physiology +14
Salt and water balance and renin activity in renal hypertension of rats
Jan Möhring, B. Möhring, H-J Naumann et al. · American Journal of Physiology-Legacy Content · 1975 · 146 citations
Medicine, Nephrology, Physiology +17